Audited Supplier
51828-95-6
2023788-19-2
C50h69n15o9
257-457-6
Pharmaceutical Intermediates
Powder
Refined
White
99%
by Sea or by Air
Prompt
MixChem
10g; 1g; 5g; 25g
Customized
Wuhan, Hubei, China
Product Description
Description:
Glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) double agonist survodutide(BI 456906) has been recognized as breakthrough therapy by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA). It is intended for the treatment of metabolic dysfunction-related steatohepatitis (MASH). Survodutide is a glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) dual agonist with a unique mechanism of action. The glucagon receptor agonist component of Survodutide increases energy expenditure and directly affects the liver, helping to improve liver fibrosis. The GLP-1 agonist group can effectively reduce appetite and increase satiety at the same time.
BENEFITS
BENEFITS
- Helps slow food leaving your stomach
- Helps prevent your liver from making too much sugar
- Helps the pancreas produce more insul when your blood sugar levels are high
- Can help control blood glucose
- Can reduce hyperglycemia, especially after meals
- Can reduce fasting insul and fasting glucose
- Can reduce hemoglobin A1c
- Can decrease appetite and caloric intake, while inhibiting weight gain
- Has been shown to lower triglyceride levels and oxidative stress from high LDL
- Has been shown to help induce weight loss in obese patients with higher dosing
- Helps decrease leptin and increase leptin sensitivity
- Can increase the conversion of white fat to brown fat
GENERIC PEPTIDES (GMP)
| # | Product | Sequence | Therapeutic Area | Form | Unit Size |
| 4109712 | Sema | H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH | Type II diabetes mellitus Obesity | Lyophilized powder | 2 mg/vial 5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial |
| 4109713 | Tirzepatide CAS No.: 2023788-19-2 | H-Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | Type II diabetes mellitus Obesity | Lyophilized powder | 10 mg/vial 15 mg/vial 20 mg/vial 30 mg/vial 60 mg/vial |
| 4109714 | Cagrilintide CAS No.: 1415456-99-3 | {Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 | Type II diabetes mellitus Obesity | Lyophilized powder | 5 mg/vial 10 mg/vial |
| 4109715 | CagriSema | Blend | Type II diabetes mellitus Obesity | Lyophilized powder | 5 mg/vial 10 mg/vial 20 mg/vial |
| 4109716 | Retatrutide CAS No. 2381089-83-2 | Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | Treatment of type 2 diabetes Treatment of obesity | Lyophilized powder | 8 mg/vial 10 mg/vial 12 mg/vial 15 mg/vial 30 mg/vial |
- We invite you to contact us at any time to obtain detailed product specifications, technical data sheets, Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), pricing information, delivery schedules, and payment terms. Your inquiries are always welcome!We specialize in the supply of a wide range of chemical intermediates, including Amidine derivatives, Guanidine derivatives, Pyrimidine derivatives, and more. Our products are meticulously designed and backed by advanced technology, ensuring their uniqueness and quality in the market.Our team, comprising highly skilled doctors and masters, brings a wealth of expertise in product development and production. With a strong university background, we are committed to innovation and excellence. We offer customized services to cater to the diverse needs of our clients, ensuring that we meet and exceed their expectations.Our facilities include three state-of-the-art laboratories and a dedicated production base. This infrastructure enables us to maintain a stable output while providing top-notch products and services to our partners.What sets us apart is our patented product portfolio and our dedication to technological advancement. We are not only suppliers but also partners in growth. We offer technology transfer services, empowering companies to enhance their technological capabilities and foster joint development.
package
weight | package |
<25kg | by foil-alum bag/pap/bottle |
≥25kg | package: 25kg/drum/bag or as your request |
